Lowered erythrocyte-sedimentation rate with sodium valproate.
D000328:Adult; D000347:Afibrinogenemia / Q000139:chemically induced; D001799:Blood Sedimentation; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy; D014635:Valproic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D014635:Valproic Acid; D005340:Fibrinogen